- Home
- WYNN vs BMRN Comparison
WYNN vs BMRN Comparison
Compare WYNN & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYNN
- BMRN
- Stock Information
- Founded
- WYNN 2002
- BMRN 1996
- Country
- WYNN United States
- BMRN United States
- Employees
- WYNN N/A
- BMRN N/A
- Industry
- WYNN Hotels/Resorts
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- WYNN Consumer Discretionary
- BMRN Health Care
- Exchange
- WYNN Nasdaq
- BMRN Nasdaq
- Market Cap
- WYNN 12.2B
- BMRN 9.9B
- IPO Year
- WYNN 2002
- BMRN 1999
- Fundamental
- Price
- WYNN $128.89
- BMRN $53.98
- Analyst Decision
- WYNN Strong Buy
- BMRN Buy
- Analyst Count
- WYNN 11
- BMRN 19
- Target Price
- WYNN $135.55
- BMRN $90.26
- AVG Volume (30 Days)
- WYNN 1.6M
- BMRN 2.8M
- Earning Date
- WYNN 11-06-2025
- BMRN 10-27-2025
- Dividend Yield
- WYNN 0.79%
- BMRN N/A
- EPS Growth
- WYNN N/A
- BMRN 59.53
- EPS
- WYNN 4.59
- BMRN 2.68
- Revenue
- WYNN $7,110,738,000.00
- BMRN $3,094,001,000.00
- Revenue This Year
- WYNN $0.86
- BMRN $13.32
- Revenue Next Year
- WYNN $4.30
- BMRN $7.51
- P/E Ratio
- WYNN $27.49
- BMRN $19.65
- Revenue Growth
- WYNN N/A
- BMRN 12.39
- 52 Week Low
- WYNN $65.25
- BMRN $50.76
- 52 Week High
- WYNN $134.23
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- WYNN 57.64
- BMRN 53.97
- Support Level
- WYNN $119.60
- BMRN $50.76
- Resistance Level
- WYNN $134.21
- BMRN $53.49
- Average True Range (ATR)
- WYNN 4.26
- BMRN 1.86
- MACD
- WYNN 0.82
- BMRN 0.11
- Stochastic Oscillator
- WYNN 66.39
- BMRN 55.38
About WYNN Wynn Resorts Limited Common stock
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.